Medicaid Provider SpendingClaims paid 2018–2024 · HHS public file
Home › PA › West Grove › NPI 1760906549
Hospital

Jennersville Hospital, LLC

Jennersville Hospital, LLC was paid $1.35M by Medicaid between Aug 2019 and Dec 2021, across 63 billing codes. Its largest line is 99284, emergency room visit (serious) — 34% of everything it billed.

33Billing provider infoJENNERSVILLE HOSPITAL, LLC
WEST GROVE, PA 19390
33aNPI1760906549assigned 08/02/2017
28Total paid$1.35M
24GClaims18,233
24DCodes billed63
24AFirst – last monthAug 2019 – Dec 2021
Compared with peers

Next to other General Acute Care Hospital providers in Pennsylvania

Rank by total paid#101 of 154
Median peer was paid$2.82M
This provider vs. median0.5×

Peers share this provider's primary NPPES type and state. Size alone says nothing about billing quality: a big agency or a hospital system is expected to sit far above the median.

Auditor's notes

Automated statistical signals. Not evidence of fraud — how these are computed.

Entity ProliferationAuthorized official CONNER, GARY controls 12+ related entities in our dataset. Read more
Box 24A · Dates of service

Paid by month

$0$100K$200K2018201920202021202220232024
Paid that monthNov–Dec 2024: claims still arriving when the file was cut, so these months run low for every provider
By year, as a table
YearClaimsPaid
2019306$9K
20204,317$251K
202113,610$1.09M
Box 24 · Service lines

What it billed for

CodeServiceShareClaimsBene. recordsPaid
99284 Emergency room visit (serious)Emergency department visit for the evaluation and management, high severity 34% 2,196 1,993 $458K
G0378 Hospital observation service, per hour 16% 292 257 $221K
T1015 A visit at a community health center or clinic (one all-in rate)Clinic visit/encounter, all-inclusive 15% 1,725 259 $199K
99285 Emergency room visit (most serious)Emergency department visit for the evaluation and management, high severity with immediate threat to life 12% 949 849 $169K
99283 Emergency room visit (moderate)Emergency department visit for the evaluation and management, moderate severity 10% 583 567 $142K
74177 Computed tomography, abdomen and pelvis; with contrast material 2.6% 174 170 $35K
77067 Screening mammography, bilateral, including computer-aided detection 1.6% 64 64 $21K
71046 Radiologic examination, chest; 2 views 1.1% 252 243 $15K
87635 Infectious agent detection by nucleic acid; SARS-CoV-2 (COVID-19), amplified probe <1% 462 442 $11K
93306 Echocardiography, transthoracic, real-time with image documentation, with and without Doppler, complete <1% 12 12 $9K
70450 Computed tomography, head or brain; without contrast material <1% 208 194 $9K
77063 Screening digital breast tomosynthesis, bilateral <1% 64 64 $8K
51 more codes
99282 Emergency department visit for the evaluation and management, low to moderate severity <1% 32 $8K
93005 Electrocardiogram, routine ECG with at least 12 leads; tracing only, without interpretation and report <1% 752 $5K
73630 <1% 33 $5K
80053 Comprehensive metabolic panel <1% 1,058 $5K
85025 Blood count; complete (CBC), automated, and automated differential WBC count <1% 1,689 $5K
80307 Drug test(s), presumptive, any number of drug classes; immunoassay <1% 171 $5K
G0480 Drug test(s), definitive, utilizing (1) drug identification methods able to identify individual drugs and distinguish between structural isomers (but not necessarily stereoisomers), including, but not limited to gc/ms (any type, single or tandem) and lc/ms (any type, single or tandem and excluding immunoassays (e.g., ia, eia, elisa, emit, fpia) and enzymatic methods (e.g., alcohol dehydrogenase)), (2) stable isotope or other universally recognized internal standards in all samples (e.g., to control for matrix effects, interferences and variations in signal strength), and (3) method or drug-specific calibration and matrix-matched quality control material (e.g., to control for instrument variations and mass spectral drift); qualitative or quantitative, all sources, includes specimen validity testing, per day; 1-7 drug class(es), including metabolite(s) if performed <1% 127 $3K
U0003 Infectious agent detection by nucleic acid (dna or rna); severe acute respiratory syndrome coronavirus 2 (sars-cov-2) (coronavirus disease [covid-19]), amplified probe technique, making use of high throughput technologies as described by cms-2020-01-r <1% 33 $2K
96374 Therapeutic, prophylactic, or diagnostic injection; intravenous push, single or initial substance <1% 384 $2K
80048 Basic metabolic panel (calcium, ionized) <1% 453 $2K
84703 <1% 367 $2K
87631 <1% 57 $2K
84484 <1% 536 $2K
96361 Intravenous infusion, hydration; each additional hour <1% 360 $1K
96375 Therapeutic injection; each additional sequential IV push <1% 288 $1K
96365 Intravenous infusion, for therapy, prophylaxis, or diagnosis; initial, up to 1 hour <1% 133 $1K
Q9967 Low osmolar contrast material, 300-399 mg/ml iodine concentration, per ml <1% 238 $900.55
71045 Radiologic examination, chest; single view <1% 278 $763.19
J7030 Infusion, normal saline solution , 1000 cc <1% 755 $674.71
81001 <1% 311 $533.47
74176 Computed tomography, abdomen and pelvis; without contrast material <1% 12 $458.97
83735 <1% 217 $440.22
83690 <1% 225 $403.52
96360 Intravenous infusion, hydration; initial, 31 minutes to 1 hour <1% 38 $373.23
96372 Therapeutic, prophylactic, or diagnostic injection; subcutaneous or intramuscular <1% 162 $343.91
81003 <1% 289 $324.93
85610 <1% 200 $313.62
J1885 Injection, ketorolac tromethamine, per 15 mg <1% 264 $229.73
96376 <1% 18 $228.06
87086 Culture, bacterial; quantitative colony count, urine <1% 81 $183.68
87040 <1% 24 $171.42
J2270 Injection, morphine sulfate, up to 10 mg <1% 71 $138.00
82962 <1% 235 $120.04
J7050 Infusion, normal saline solution, 250 cc <1% 128 $104.67
J7120 Ringers lactate infusion, up to 1000 cc <1% 75 $94.28
82550 <1% 29 $86.28
J2405 Injection, ondansetron hydrochloride, per 1 mg <1% 255 $78.72
83605 <1% 30 $67.20
94760 <1% 118 $65.84
J3490 Unclassified drugs <1% 67 $34.31
85730 <1% 14 $30.00
J2001 Injection, lidocaine hcl for intravenous infusion, 10 mg <1% 47 $10.76
87186 <1% 13 $8.00
J0696 Injection, ceftriaxone sodium, per 250 mg <1% 16 $7.54
87077 <1% 13 $7.10
J1200 Injection, diphenhydramine hcl, up to 50 mg <1% 15 $4.02
J3010 Injection, fentanyl citrate, 0.1 mg <1% 35 $3.27
J2060 Injection, lorazepam, 2 mg <1% 19 $1.83
J2250 Injection, midazolam hydrochloride, per 1 mg <1% 46 $1.64
94640 Pressurized or nonpressurized inhalation treatment for acute airway obstruction 0% 16 $0.00
00000 0% 425 $0.00

Claims and beneficiary counts add up across code × month rows, so one patient seen every month counts many times. Rows with fewer than 12 claims are suppressed by HHS, so small lines can be missing.

From NPPES

Who's on the registration

Authorized officialCONNER, GARY (VP & CFO)
Same official

Other billing entities under CONNER, GARY

Full network →
ProviderLocationPaid
Chestnut Hill Hospital, LLCPhiladelphia, PA$9.52M
Brandywine Hospital, LLCCoatesville, PA$2.97M
West Grove Clinic Company LLCWest Grove, PA$157K
Tower Health Medical GroupWyomissing, PA$98K
Tower Health Medical GroupWyomissing, PA$84K
STC Pediatrics LLCPhiladelphia, PA$24K
Tower Drexel Academic Medical Group LLCPhiladelphia, PA$18K
Tower Health Urgent Care, LLCKennett Square, PA$9K
Tower Health Urgent Care, LLCPhiladelphia, PA$8K
Tower Health Urgent Care, LLCPhiladelphia, PA$4K
Tower Health Urgent Care, LLCDoylestown, PA$3K
Tower Health Medical GroupWest Reading, PA$2K

Matched on the authorized-official name exactly as entered in NPPES. A common name can match unrelated people.